Welcome!

News Feed Item

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703947/Aortic-Valve-Stenosis-Global-Clinical-Trials-Review-H2-2014.html

Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Aortic Valve Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aortic Valve Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aortic Valve Stenosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Aortic Valve Stenosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Aortic Valve Stenosis 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Aortic Valve Stenosis Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Edwards Lifesciences Corporation 30
Clinical Trial Overview of Edwards Lifesciences Corporation 30
CryoLife, Inc. 31
Clinical Trial Overview of CryoLife, Inc. 31
AstraZeneca PLC 32
Clinical Trial Overview of AstraZeneca PLC 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Merck & Co., Inc. 34
Clinical Trial Overview of Merck & Co., Inc. 34
Direct Flow Medical, Inc. 35
Clinical Trial Overview of Direct Flow Medical, Inc. 35
Cerenis Therapeutics SA 36
Clinical Trial Overview of Cerenis Therapeutics SA 36
A. Menarini Industrie Farmaceutiche Riunite Srl 37
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 37
Clinical Trial Overview of Top Institutes / Government 38
National Heart, Lung, and Blood Institute 38
Clinical Trial Overview of National Heart, Lung, and Blood Institute 38
Erasmus MC 39
Clinical Trial Overview of Erasmus MC 39
Assistance Publique - Hopitaux de Paris 40
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 40
Washington University School of Medicine 41
Clinical Trial Overview of Washington University School of Medicine 41
Charles University 42
Clinical Trial Overview of Charles University 42
University of Edinburgh 43
Clinical Trial Overview of University of Edinburgh 43
Asan Medical Center 44
Clinical Trial Overview of Asan Medical Center 44
Helsinki University Central Hospital 45
Clinical Trial Overview of Helsinki University Central Hospital 45
Aarhus University Hospital 46
Clinical Trial Overview of Aarhus University Hospital 46
Sahlgrenska University Hospital 47
Clinical Trial Overview of Sahlgrenska University Hospital 47
Five Key Clinical Profiles 48
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Aortic Valve Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Aortic Valve Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Aortic Valve Stenosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Aortic Valve Stenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Aortic Valve Stenosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Aortic Valve Stenosis Therapeutics, Global, Suspended Clinical Trials, 2014* 23
Aortic Valve Stenosis Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Aortic Valve Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Edwards Lifesciences Corporation, 2014* 30
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CryoLife, Inc., 2014* 31
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 32
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 34
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Direct Flow Medical, Inc., 2014* 35
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cerenis Therapeutics SA, 2014* 36
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014* 37
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 38
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 39
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 40
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 41
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Charles University, 2014* 42
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Edinburgh, 2014* 43
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014* 44
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2014* 45
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2014* 46
Aortic Valve Stenosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2014* 47

List of Figures
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Aortic Valve Stenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Aortic Valve Stenosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Aortic Valve Stenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Aortic Valve Stenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Aortic Valve Stenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Aortic Valve Stenosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Aortic Valve Stenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Aortic Valve Stenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 70


Read the full report:
Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/703947/Aortic-Valve-Stenosis-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
My team embarked on building a data lake for our sales and marketing data to better understand customer journeys. This required building a hybrid data pipeline to connect our cloud CRM with the new Hadoop Data Lake. One challenge is that IT was not in a position to provide support until we proved value and marketing did not have the experience, so we embarked on the journey ourselves within the product marketing team for our line of business within Progress. In his session at @BigDataExpo, Sum...
SYS-CON Events announced today that Loom Systems will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2015, Loom Systems delivers an advanced AI solution to predict and prevent problems in the digital business. Loom stands alone in the industry as an AI analysis platform requiring no prior math knowledge from operators, leveraging the existing staff to succeed in the digital era. With offices in S...
The taxi industry never saw Uber coming. Startups are a threat to incumbents like never before, and a major enabler for startups is that they are instantly “cloud ready.” If innovation moves at the pace of IT, then your company is in trouble. Why? Because your data center will not keep up with frenetic pace AWS, Microsoft and Google are rolling out new capabilities In his session at 20th Cloud Expo, Don Browning, VP of Cloud Architecture at Turner, will posit that disruption is inevitable for c...
SYS-CON Events announced today that Telecom Reseller has been named “Media Sponsor” of SYS-CON's 20th International Cloud Expo, which will take place on June 6–8, 2017, at the Javits Center in New York City, NY. Telecom Reseller reports on Unified Communications, UCaaS, BPaaS for enterprise and SMBs. They report extensively on both customer premises based solutions such as IP-PBX as well as cloud based and hosted platforms.
SYS-CON Events announced today that Ocean9will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Ocean9 provides cloud services for Backup, Disaster Recovery (DRaaS) and instant Innovation, and redefines enterprise infrastructure with its cloud native subscription offerings for mission critical SAP workloads.
Providing the needed data for application development and testing is a huge headache for most organizations. The problems are often the same across companies - speed, quality, cost, and control. Provisioning data can take days or weeks, every time a refresh is required. Using dummy data leads to quality problems. Creating physical copies of large data sets and sending them to distributed teams of developers eats up expensive storage and bandwidth resources. And, all of these copies proliferating...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
In recent years, containers have taken the world by storm. Companies of all sizes and industries have realized the massive benefits of containers, such as unprecedented mobility, higher hardware utilization, and increased flexibility and agility; however, many containers today are non-persistent. Containers without persistence miss out on many benefits, and in many cases simply pass the responsibility of persistence onto other infrastructure, adding additional complexity.
SYS-CON Events announced today that Cloudistics, an on-premises cloud computing company, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Cloudistics delivers a complete public cloud experience with composable on-premises infrastructures to medium and large enterprises. Its software-defined technology natively converges network, storage, compute, virtualization, and management into a ...
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Pentaho has announced orchestration capabilities that streamline the entire machine learning workflow and enable teams of data scientists, engineers and analysts to train, tune, test and deploy predictive models. Pentaho’s Data Integration and analytics platform ends the ‘gridlock’ associated with machine learning by enabling smooth team collaboration, maximizing limited data science resources and putting predictive models to work on big data faster – regardless of use case, industry, or languag...
SYS-CON Events announced today that T-Mobile will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on ...
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor - all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.